Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5459072 in Primary Sjogren's Syndrome
NCT02701985Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of petesicatib, sponsored by Roche. Started Jul 2016; status: completed.
02
Drugs
petesicatib
Beyond the preview
Go deeper on NCT02701985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02701985.